Sphera Funds Management Ltd. Orgenesis Inc. Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.77 - $8.08 $170,346 - $288,552	-35,712 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.4 - $5.63 $1.6 Million - $2.04 Million	-363,091 Reduced 91.05%	35,712 $161,000
Q3 2020 Nov 12, 2020	SELL	$4.75 - $5.99 $1.27 Million - $1.6 Million	-266,964 Reduced 40.1%	398,803 $2.01 Million
Q2 2020 Aug 13, 2020	SELL	$3.6 - $7.84 $1.6 Million - $3.48 Million	-443,797 Reduced 40.0%	665,767 $4.05 Million
Q1 2020 May 14, 2020	BUY	$2.76 - $5.44 $3.06 Million - $6.04 Million	1,109,564 New	1,109,564 $4.22 Million

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.